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Functional and molecular characterization of a peritoneal
dialysis model in the C57BL/6J mouse.
Background. Animal models are important for understand-
ing the physiology and pathophysiology of peritoneal transport
during peritoneal dialysis (PD). Mechanistic investigations of
rat and rabbit models of PD are mostly based on interven-
tion studies using pharmacologic agents or blocking antibodies.
These models may be limited by the time-course, lack of speci-
ficity, or side effects of such interventions. Genetically modified
mice could provide an attractive alternative to the above mod-
els. In this study, we have characterized PD parameters and
tested the effect of gender and dialysate volume and/or osmo-
lality in the C57BL/6J mouse.
Methods. Mice were submitted to a 2-hour peritoneal equi-
libration test in order to obtain permeability parameters. The
expression of the water channel aquaporin-1 (AQP1) and en-
dothelial NO synthase (eNOS) was investigated at the pro-
tein (immunoblotting, immunostaining) and mRNA [real-time
reverse-transcription-polymerase chain reaction (RT-PCR)]
levels. The potential effect of gender on these parameters was
also studied.
Results. Exposure of mice to 2 mL of 3.86% glucose dialysate
yielded equilibration curves for urea and glucose, a sodium siev-
ing, and a net ultrafiltration (UF) that were remarkably simi-
lar to those obtained in rats. The increase in dialysate volume
(from 2 mL to 3 mL and 6 mL) resulted in a higher ultrafiltration
and, for the highest volume, an increase in the diffusive mass
transport coefficient (MTAC) for urea. The increase in dialysate
glucose concentration (from 1.36% to 3.86% and 7%) resulted
in increased sodium sieving and higher UF, whereas the MTAC
for urea was unchanged. In comparison with males, females had
a similar peritoneal transport rate for small solutes but a signif-
icantly lower sodium sieving, reflecting a lower AQP1 mRNA
and protein expression in the peritoneum.
Conclusion. These data demonstrate the structural and func-
tional similarity between mouse and rat models of PD, and fur-
ther emphasize the relevance of mouse models to understand
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PD in humans. They also suggest that gender may influence
water transport and AQP1 expression in the peritoneum.
Peritoneal dialysis (PD) is an established mode of re-
nal replacement therapy used in more than 130,000 pa-
tients worldwide. In parallel with clinical developments
to reduce the impact of acute and chronic complications
of PD, there has been a growing interest in establish-
ing suitable experimental models to better understand
the physiology and pathophysiology of fluid and solutes
transport across the peritoneal membrane (PM). Thus
far, most of the experimental studies of peritoneal trans-
port have been performed in dog, rabbit, and rat models
(reviewed in [1]). These studies yielded essential infor-
mation on the kinetics of peritoneal transport and ul-
trafiltration (UF) in both normal and acute peritonitis
conditions [2, 3]. They also established that the capillary
endothelium, which expresses both the endothelial nitric
oxide synthase (eNOS) and the water channel aquaporin-
1 (AQP1) [4], constitutes the major barrier for solutes
and water transport during PD [2, 3]. The amount of per-
fused capillaries within the PM determines the so-called
“effective peritoneal surface area” (EPSA), which is the
functional area of exchange between blood and dialysate
[5].
Understanding the molecular mechanisms involved in
peritoneal permeability is of cardinal importance to de-
veloping new therapeutic strategies targeting the com-
plications of PD. Thus far, mechanistic investigations of
peritoneal permeability in rat and rabbit models of PD
were mostly based on intervention studies using phar-
macologic agents, blocking antibodies, or transient ex-
pression systems including adenoviral vectors [6]. These
models are often limited by a lack of specificity, side ef-
fects, as well as a transient efficacy and safety concerns
[6–8].
Until recently, the body size of a species was considered
as the major limiting factor to perform in vivo studies of
PD [1]. This restriction is no longer applicable due to the
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availability of microsample analysis and molecular biol-
ogy techniques, allowing the investigation of permeabil-
ity parameters and multiple molecules at the mRNA and
protein levels from minute volumes and tissue samples.
These new possibilities led us to propose that genetically
modified mice could provide an attractive alternative to
the above models to investigate the molecular counter-
parts of PD [9]. Since the 1980s, the mouse has emerged
as the preeminent model organism for investigations of
many aspects of human diseases, as well as basic human
biology at the cellular, tissular, and whole organism lev-
els. As an experimental model for mammalian biology,
the mouse offers critical advantages, including low cost,
fast turnover, easy breeding, and multiple possibilities of
genetic manipulations. The latter benefit from the avail-
ability of the 2.5 Gb genome sequence from the C57BL/6J
mouse strain, which was shown to contain about 30,000
protein-coding genes, 99% of which have a sequence
match in the human genome [10].
Recently, we have used knockout mice to validate
biochemical and pharmacologic studies previously per-
formed in rat models [11, 12]. These studies demonstrated
that eNOS plays a critical role in the permeability mod-
ifications and structural changes (vascular proliferation,
mononuclear cells infiltrate) associated with acute peri-
tonitis [9]. In this paper, we provide a more detailed anal-
ysis of the structure of the peritoneum in the C57BL/6J
mouse, the distribution and tissue expression of the key
molecules AQP1 and eNOS, and the transport parame-
ters at baseline, and following modifications of dialysate
volume and osmolality. Because the potential effect of
gender on solute and fluid transport across the PM re-
mains unknown, we also took advantage of this mouse
model to evaluate this question. Our results demon-
strate the structural and functional similarity between
mouse and rat models of PD and further emphasize the
relevance of mouse models to understand PD in humans.
They also suggest that gender may influence water trans-
port and AQP1 expression in the PM.
METHODS
Experimental animals
Experiments were conducted using C57 BL/6J mice
(Iffa Credo, Brussels, Belgium), aged 8 to 10 weeks (body
weight, BW: 18-26 g), since this background is one of
the most common in genetically modified mice. All ani-
mals had access to standard diet and tap water ad libitum.
The experiments were conducted in accordance with the
National Research Council Guide for the Care and Use of
Laboratory Animals and the local Ethics Committee. A
first series of 16 mice was used to investigate the effect of
dialysate volume on transport parameters, in comparison
with those obtained in male Wistar rats (Iffa Credo, aged
8–10 weeks, BW: 275-350 g). A second series of 18 mice
was used to investigate the effect of different dialysate
glucose concentrations. A third series of 24 mice (12 males
and 12 females) was used to investigate the effect of gen-
der. A fourth series of 3 mice was used to study the rela-
tionship between intraperitoneal pressure (IPP) and the
inflow volume. A fifth series of 8 mice was used to investi-
gate the effect of sample volume on peritoneal transport
parameters.
Peritoneal transport studies and tissue sampling
Mice were submitted to a 2-hour peritoneal equili-
bration test (PET) to measure small solute transport
parameters [9, 11]. Following anesthesia with ketamine
(100 mg/kg SC, Merial, Brussels, Belgium) and xy-
lazine (10 mg/kg SC, Bayer, Brussels, Belgium), mice
were laid in a supine position on a thermopad at 37◦C.
The right common carotid artery was canulated for blood
sampling and the measurement of mean arterial blood
pressure (MABP) using an isotonic blood pressure trans-
ducer (Harvard Apparatus, Holliston, MA, USA). The
right jugular vein was catheterized for saline infusion
(0.9% NaCl, 0.3 mL/h). After 30 minutes of stabiliza-
tion, the fur over the abdominal wall of the mice was
cleanly shaved. A silicon catheter (Venflon 22 G, 0.9 mm
diameter, Terumo, Leuven, Belgium) was inserted percu-
taneously to the right lower quadrant of the peritoneal
cavity. This catheter was used for dialysate fluid infu-
sion and sampling. The appropriate volume of dialysate
(Dianeal, Baxter, Nivelles, Belgium) was infused.
Dialysate samples (100 lL) were taken from the bag at
0 minutes, and from the Venflon catheter at 30 minutes
and 60 minutes, and at the end of the dwell (120 min-
utes). Prior to each sampling, 50 to 100 lL of the dialysate
was flushed back and forth, and the abdomen was gen-
tly agitated to facilitate fluid mixing. At the end of the
dwell, most of the dialysate was recovered from the peri-
toneal cavity and the volume measured with a precision
pipette (margin of error: 10 lL). The remaining dialysate
in the peritoneal cavity was collected using gauze tis-
sue, which was weighed on a precision balance (AG35,
Mettler Toledo, Zaventem, Belgium) to calculate the vol-
ume (margin of error, 1 lL). The fluid taken from gauze
tissue accounted for ∼5% of total volume of dialysate
when using 2 mL of 3.86% glucose dialysate. These pa-
rameters were used to measure net UF, as previously de-
scribed, and validated [9, 11]. Dialysate white blood cells
(WBCs) were counted using a hemocytometer (Marien-
feld, Lauda, Germany). Blood samples (100 lL) were
taken from carotid artery at time 0, 30 minutes, and 60
minutes, and at the end of the dwell (exsanguination, 120
minutes). Hematocrit was measured before PD exchange.
Urea, glucose, sodium were assayed using a Kodak
Ektachem DT60 II and DTE II analyser (Eastman Ko-
dak Company, Rochester, NY, USA). None of the mice
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investigated died during anesthesia and PD protocol. At
the end of the dwell, animals were sacrificed by exsan-
guination, and peritoneum samples were processed for
fixation and protein extraction [9, 11]. Samples from the
visceral and parietal peritoneum were fixed for 3 hours
at 4◦C in 4% paraformaldehyde in 0.1 mol/L phosphate
buffer, rinsed, and embedded in paraffin. Samples from
the visceral peritoneum were snap-frozen in liquid nitro-
gen and stored at −80◦C.
The transport of small solute was evaluated by the
mass transfer area coefficient (MTAC) of urea, using the
Garred two-sample model [13]:
MTAC = Vav/t120′
× ln[volumein(P − D0)/Volumeout(P − Dt)],
in which Vav is the average of the initial and final volumes;
P, the plasma concentration of urea; Dt, the dialysate con-
centration of urea at the end of the dwell; D0, the initial
concentration of urea in dialysate, which is set at 0.
A unified formula was used to calculate the body sur-
face area (BSA) in mice and rats, using the appropriate
correction for the L parameter [14].
Intraperitoneal pressure measurement
A direct assessment of the IPP was obtained on anes-
thetized mice using a catheter that was inserted in the
peritoneal cavity and connected to a vertical, graduated
polyethylene line (0.5 mm diameter). The circuit was
filled with 0.5 mL of 3.86% glucose dialysate and, af-
ter zeroing at the level of the heart, left at atmospheric
pressure. Variable volumes of 3.86% glucose dialysate
were then instilled in the peritoneal cavity (via a cock
in the circuit), and the increase in the column of stan-
dard dialysate (in cm H2O vs. the zero defined above)
was read on the graduated scale after stabilization. Each
measurement was performed on 3 mice in duplicate.
Real-time RT-PCR
Mouse peritoneum samples were homogenized in
Trizol (Invitrogen, Merelbeke, Belgium). RNA samples
were treated with DNAse I (MBI Fermentas GMBH, St.
Leon-Rot, Germany) and reverse transcribed into cDNA
by using Superscript II (Invitrogen). The primers used for
polymerise chain reaction (PCR) amplification were the
following:
AQP1 (exons 1–2) sense 5′ GCTGTCATGTATATCA
TCGCCCAG 3′ and antisense 5′ AGGTCATTTCGGC
CAAGTGAGT 3′, GAPDH (exon 1) sense 5′ TGCAC
CACCAACTGCTTAGC 3′ and antisense 5′ GGATGC
AGGGATGATGTTCT 3′, eNOS (exon 8–9) sense
5′ CTCCCAGCTGTGTCCAACAT 3′ and antisense
5′ CACACAGCCACATCCTCAAG 3′. The predicted
lengths of the resulting PCR fragments were 107 bp
(AQP1), 176 bp (GAPDH), and 149 bp (eNOS).
Real-time reverse transcription (RT)-PCR (iCycler;
BioRad, Hercules, CA, USA) analyses were performed
in duplicate with 200 nmol/L of both sense and anti-
sense primers in a final volume of 25 lL using iSupermix
(BioRad). PCR conditions were settled as incubation at
94◦C for 3 minutes, followed by 40 cycles of 30 seconds
at 95◦C, 30 seconds at 61◦C, and 1 minute at 72◦C. The
melting temperature of PCR product was checked at
the end of each PCR by recording SYBR Green fluo-
rescence increase upon slowly renaturing DNA. A con-
trol PCR without template DNA was performed in each
experiment. To determine the absolute copy number of
the target transcript, a cloned plasmid DNA for AQP1,
eNOS, and GAPDH was used to generate a standard
curve. The PCR products were cloned into a pTZ57R
vector (MBI Fermentas) and transformed in JM 107 com-
petent cells (MBI Fermentas, St. Leon-Rot, Germany).
A standard curve was generated from serial 10-fold dilu-
tions of the purified plasmid containing the appropriate
cDNA. Regression analyses of the Ct (threshold cycle)
values of the standard dilution series were used to deter-
mine the amplification efficiency. The absolute amount of
molecules in the experimental samples was determined
by extrapolating the Ct values from the standard curves.
The standardized ratio (molecule × mRNA/GAPDH
mRNA) will be referred to as the relative amount of
molecule × mRNA [15].
Antibodies
The antibodies included a monoclonal antibody
against eNOS (Transduction Laboratories, Lexington,
KY, USA); a monoclonal antibody against b-actin
(Sigma, St. Louis, MO, USA); and an affinity-purified
rabbit antibody against AQP1 (Chemicon International,
Temecula, CA, USA).
Immunoblotting
Sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and immunoblotting were per-
formed as described [9, 11]. Protein extracts were
separated on 12% acrylamide slabs and transferred to
nitrocellulose. Efficiency of transfer to nitrocellulose was
tested by Ponceau red (Sigma) and immunoreactivity for
b-actin. The membranes were blocked for 30 minutes,
incubated overnight with the primary antibody at 4◦C,
washed, incubated for 1 hour with peroxidase-labeled
secondary antibodies (Dako, Glostrup, Denmark), and
visualized with enhanced chemiluminescence (Amer-
sham, Little Chalfont, UK). The immunoblots were per-
formed in duplicate, and specificity was determined by
comparison with positive controls. Densitometry analysis
was performed with a StudioStar Scanner (Agfa-Gevaert,
Mortsel, Belgium) using the NIH-Image V1-57 software.
The signal was normalized over b-actin and expressed as
arbitrary units (AU).
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Fig. 1. Morphology and distribution of
AQP1 and eNOS in mouse peritoneum:
Light microscope level. Hemalun-eosine
staining (A and B) and immunostaining for
AQP1 (C and D) and eNOS (E) in parietal
(A) and visceral (B to E) peritoneum of
control mice. Panel A shows the right side
of the lower anterior abdominal wall distant
from the site of catheter insertion, whereas
panels B to E show the omentum. The insets
illustrate the cytoplasmic extensions that are
observed on the luminal side of mesothelial
cells. These extensions include microvilli
and primary cilia. Immunoreactivity for
AQP1 (C-D, 1:200 dilution) is located in
the endothelium lining peritoneal capillaries
and venules, but not in small arterioles (∗),
whereas eNOS (E, 1:250 dilution) is located
in the endothelium lining all types of blood
vessels, including capillaries and venules and
small arteries (∗). Original magnification: A,
B, C: ×150; insets: ×300; D, E: ×300.
Tissue staining and immunohistochemistry, electron
microscopy and immunogold staining
Hemalun-eosine staining and immunostaining were
performed as previously described [11]. After blocking
in 0.3% H2O2 and incubation with 10% normal serum,
sections were incubated successively for 45 minutes each
with the primary antibody, biotinylated IgG, and avidin-
biotin peroxidase (Vector Laboratories, Burlingame, CA,
USA). The MOM immunodetection kit (Vector Labo-
ratories) was used for monoclonal antibodies on mouse
tissue. Immunolabeling was visualized using aminoethyl-
carbazole (Vector Laboratories). Sections were viewed
under a Leica DMR coupled to a Leida DC 300 camera
(Leica, Heerbrugg, Switzerland). The specificity of im-
munolabeling was confirmed by incubation without pri-
mary antibody, and with nonimmune IgG (Dako).
For transmission electron microscopy, mouse vis-
ceral or parietal peritoneum was fixed overnight in 4%
parafomaldehyde in phosphate-buffered saline (PBS),
and washed extensively in PBS. Small pieces of peri-
toneum tissue were embedded either in Unicryl (for
gold labeling) or in epon, after 1-hour postfixation in
1% sodium tetroxide and 1.5% potassium ferrocyanide
(for Karnovski staining [16]). Seventy-nm thick sections
were cut on a Leica ultramicrotome and collected on car-
bon/formvar coated nickel grids. For staining, sections
were counterstained in 0.2% lead citrate for 1 minute
and dried. For gold labeling, the tissue sections were incu-
bated in buffer-T containing 0.1% bovine serum albumin
(BSA), 0.05% Tween-20 in 100 mmol/L Tris-HCl, pH 7.5,
for 30 minutes, followed by 2 hours with the anti-AQP1
primary antibody (3 lg/mL final dilution) in buffer-T as
previously reported [17]. Sections were washed 6 × 5 min
in buffer-T and incubated in a 1:20 dilution of 10 nm gold-
conjugated antirabbit antibodies (Amersham) in buffer-
T for 45 minutes. Sections were washed 6 × 5 minutes,
then stained for 3 minutes in 5% uranyl acetate followed
by lead citrate. Karnovski-stained or gold-labeled sec-
tions were observed at the electron microscope and pho-
tographed at 8000 to 13,000 × final magnification.
Data analysis
Data are presented as mean ± SEM. Comparisons be-
tween results from different groups were performed us-
ing one-way analysis of variance (ANOVA), followed by
Bonferroni’s multiple comparison test. Significance level
was P < 0.05.
RESULTS
Structure of the mouse peritoneum, distribution of AQP1
and eNOS
Examination at the light microscope level showed that
both the visceral and parietal surfaces of mouse peri-
toneum included a mesothelium covering a thin layer of
connective tissue containing capillaries and blood ves-
sels (Fig. 1A and B). At higher magnification, numerous
cytoplasmic extensions (including microvilli and primary
cilia) were identified on the luminal side of mesothelial
cells. These structures were more abundant, and appar-
ently higher in the visceral peritoneum (Fig. 1A and B,
insets). Immunostaining was performed to document the
distribution of the endothelial markers AQP1 and eNOS
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Fig. 2. Mouse peritoneum: Transmission
electron microscopy and immunogold
staining for AQP1. Transmission electron
microscopy (Karnovski staining) of the vis-
ceral (A) and parietal (B) mouse peritoneum
shows the thin mesothelial cells (m), bundles
of collagen fibers (c), and the endothelial cells
(E) lining peritoneal capillaries. The endo-
thelial cells exhibit numerous caveolae and
plasma membrane infoldings. Muscle fibers
(M) are identified in the visceral peritoneum,
and the capillary lumen (L) contains a red
blood cell (RBC) (B). Immunoelectron
microscopy identified AQP1 in the apical
and basolateral plasma membranes of the
endothelial cells lining peritoneal capillaries
(C), whereas no signal was detected in the
mesothelial cells (D). All panels: bar, 0.5 lm.
N, nucleus.
in the PM. In both the visceral and parietal peritoneum,
AQP1 was expressed in capillaries and small venules, but
not in arterioles (Fig. 1C and D), whereas eNOS was lo-
cated in the endothelium lining all types of blood ves-
sels in the peritoneum (Fig. 1E). Transmission electron
microscopy of the visceral and parietal peritoneum iden-
tified the thin layer of mesothelial cells, the interstitium
containing bundles of collagen fibers, and the endothe-
lial cells lining peritoneal capillaries (Fig. 2A and B).
Immunoelectron microscopy identified AQP1 in the api-
cal and basolateral plasma membranes of the endothelial
cells lining peritoneal capillaries, whereas no signal was
detected in the mesothelial cells (Fig. 2C and D). Alto-
gether, the structure of the PM and the distribution of
AQP1 and eNOS were similar in mouse (present study)
and rat and human peritoneum [17–19].
Peritoneal transport studies in mouse
All groups of C57 BL/6J male mice were similar in
terms of body weight, hematocrit, and mean blood pres-
sure (Table 1). None of the mice suffered from peritonitis,
based on clear dialysate, low WBC count in the dialysate,
and lack of infiltrate on morphologic examination.
Basal transport parameters. Exposure of mice to 2 mL
of 3.86% glucose dialysate (Table 2, Fig. 3) induced a pro-
gressive increase in the dialysate-over-plasma (D/P) ratio
for urea, a progressive reabsorption of glucose from the
dialysate, a sodium sieving, and a net UF averaging 30
lL/g BW. The inflow volume of 2 mL was first tested in
mouse, based on the relationship of BSA between mouse
and rat and the fact that a 15 mL inflow volume is mostly
used in rat models (Table 3). As expected, the mouse
versus rat scaling was reflected in terms of MTAC for
urea. The D120/D0 glucose and net UF (normalized for
BW) parameters were similar in mouse and rat, confirm-
ing our previous observations [9]. Control experiments
have shown that reducing the sampling volume during
the dwell (from 200 to 100 lL of dialysate and from 300
to 150 lL of plasma) did not influence the transport pa-
rameters (data not shown).
Influence of the dialysate inflow volume. Exposure to
higher dialysate volumes (3 mL and 6 mL) was associ-
ated with a significant increase in net UF, associated with
increased D120/D0 glucose values reflecting the larger
supply of glucose (Table 2). The MTAC for urea was
unchanged in 3 mL group, but significantly increased in
the 6 mL inflow group, probably due to the increased fluid
contact surface area of the peritoneum. It must be noted
that inflow volumes >6 mL were reflected by an exponen-
tial increase in the IPP, whereas the method used did not
allow a precise determination for lower volumes (data
not shown). These results indicated that a progressive
increase in the inflow volume was reflected by increased
UF, whereas small solute transport (monitored by MTAC
urea) increased only with very large inflow volume.
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Table 1. Clinical and biological parameters in mice: Effects of dialysate volume, dialysate glucose concentration, and gender
Dialysate volume
Glucose Body weight Hematocrit Dialysate WBC MABP
Dialysate volume % N g % ×104/mL mm Hg
2 mL 3.86 6 24 ± 1 48 ± 1 49 ± 3 79 ± 2
3 mL 3.86 6 25 ± 1 46 ± 1 44 ± 8 81 ± 4
6 mL 3.86 4 24 ± 0.5 48 ± 1 56 ± 6 81 ± 3
Dialysate glucose concentration
Glucose Body weight Hematocrit Dialysate WBC MABP
Dialysate volume % N g % ×104/mL mm Hg
2 mL 1.36 6 24 ± 0.5 49 ± 1 45 ± 5 80 ± 2
2 mL 3.86 6 24 ± 1 50 ± 1 49 ± 3 79 ± 2
2 mL 7 6 25 ± 0.5 48 ± 1 56 ± 3 79 ± 6
Gender
Body weight Hematocrit Dialysate WBC MABP
Gender (volume, % glucose) N g % ×104/mL mm Hg
Male 2 mL, 7% 6 25 ± 0.5 47 ± 1 46 ± 5 78 ± 3
Female 2 mL, 7% 6 19 ± 0.5a 49 ± 1 45 ± 6 84 ± 3
WBC, white blood cells; MABP, mean arterial blood pressure. Clinical and hematocrit parameters were recorded before starting the dwell, whereas WBC counts
were obtained at T120.
aP < 0.05 vs. male mice.
Table 2. Water and small solutes transport in mice: Effects of dialysate volume, dialysate glucose concentration, and gender
Dialysate volume
Glucose Net UF/BW Na+ sieving MTAC urea
Dialysate volume % N lL/g % lL/min D120/D0 glucose
2 mL 3.86 6 34 ± 1.4 6.3 ± 0.5 22 ± 1.3 0.35 ± 0.02
3 mL 3.86 6 48 ± 3.1a 6.9 ± 0.9 23 ± 1.2 0.48 ± 0.01a
6 mL 3.86 4 57 ± 0.9a,b 7.5 ± 1.4 33 ± 3.1a,b 0.60 ± 0.02a,b
Dialysate glucose concentration
Glucose Net UF/BW Na+ sieving MTAC urea
Dialysate volume % N lL/g % lL/min D120/D0 glucose
2 mL 1.36 6 4 ± 1.6 −4.9 ± 1.8 24 ± 0.3 0.55 ± 0.02
2 mL 3.86 6 33 ± 2.0c 6.1 ± 1.3c 24 ± 1.9 0.35 ± 0.02c
2 mL 7 6 57 ± 4.0c,d 11.7 ± 0.7c,d 25 ± 2.8 0.32 ± 0.01c
Gender
Dialysate Net UF/BW Na+ sieving MTAC urea
Gender (volume, % glucose) N lL/g % lL/min D120/D0 glucose
Male 2 mL, 7% 6 62 ± 1.1 11.6 ± 0.9 21 ± 2.7 0.31 ± 0.01
Female 2 mL, 7% 6 70 ± 4.0 8.8 ± 0.6e 20 ± 2.9 0.33 ± 0.01
BW, body weight; UF, ultrafiltration; MTAC, mass transfer coefficient (lL/min).
aP < 0.05 vs. 2 mL; bP < 0.05 vs. 3 mL; cP < 0.05 vs. 1.36%; dP < 0.05 vs. 3.86%; eP < 0.05 vs. male mice.
Influence of the dialysate osmolality. In order to ver-
ify that the osmotic gradient induced by glucose in the
dialysate was the primary factor influencing water per-
meability and net UF, we exposed mice to a 2-hour PD
exchange using 1.36%, 3.86%, and 7% glucose dialysates
(Table 2, Fig. 3). The peritoneal transport for small so-
lutes (MTAC for urea) was similar in the 3 groups,
whereas D120/D0 glucose decreased when using high glu-
cose concentrations (Table 2). Contrasting with the lack
of sodium sieving when using the 1.36% glucose, a sig-
nificant sodium sieving was observed when using 3.86%
glucose (% decrease in D/P sodium between T30 and T0:
6.1 ± 1.3%), and even further with 7% glucose (11.7 ±
0.7%). These differences were reflected in terms of net
UF, which increased from 4 ± 1.6 lL/g BW (1.36% glu-
cose) to 33 ± 2 lL/g BW (3.86% glucose) and further to
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Fig. 3. Peritoneal permeability parameters
in mouse: Effect of glucose concentration. The
dialysate-to-plasma (D/P) ratio of urea (A),
the progressive removal of glucose from the
dialysate (D/D0 glucose; B), the sodium siev-
ing (% decrease in D/P sodium from T0 to
T30; C) and net ultrafiltration (UF; D) were
determined during a 2-hour exchange with
2 mL of dialysates containing 1.36% (black
squares), 3.86% (open squares), and 7% glu-
cose (black inverted triangles). In compari-
son with 1.36% glucose, exposure to 3.86%
and 7% glucose dialysates induced a signif-
icant and graduated increase in glucose ab-
sorption, sodium sieving, and net UF. ∗P <
0.05 vs. 1.36% glucose dialysate; §P < 0.05 vs.
3.86% glucose dialysate.
Table 3. Comparisons between net ultrafiltration (UF), small solute transport (D120/D0 glucose; MTAC urea), body weight (BW), and body
surface area (BSA) in mice and rats submitted to a PD exchange with 3.86% glucose
Dialysate volume Net UF MTAC urea BW BSAa
Species N mL lL/g BW D120/D0 glucose mL/min g cm2
Mouse 6 2 29 ± 3.1 0.35 ± 0.02 0.023 ± 0.002 24.4 ± 0.7 70 ± 1
Rat 5 15 25 ± 2.9 0.33 ± 0.01 0.14 ± 0.01 326 ± 17 423 ± 10
Ratio (mouse/rat) 1/7 1/0.9 1/0.9 1/6 1/13 1/6b
aBSA was calculated using the unified formula [14].
bA similar ratio was obtained when using the 0.7th power of the BW relationship.
57 ± 4 lL/g BW (7% glucose). It must be noted that the
use of hypertonic dialysate was associated with a gradual
decrease in the MABP during the dwell (1.36% glucose:
from 78 ± 2 mm Hg at T0 to 58 ± 3 mm Hg at T120;
7% glucose: from 79 ± 6 mm Hg at T0 to 50 ± 2 mm Hg
at T120). These data confirm that the osmotic gradient
generated by glucose in the dialysate generates transep-
ithelial water transport, reflected by the sodium sieving,
and determines net UF across the PM in mouse.
Influence of gender on transport and structural parame-
ters in mouse peritoneum
In order to investigate whether gender may influence
the PM in mouse, we carefully monitored transport pa-
rameters and the expression of AQP1 and eNOS in
age-matched male and female mice. In comparison with
males, females were characterized by a significantly lower
BW (Table 1). Evaluation of peritoneal transport was per-
formed using 7% glucose dialysate to maximize the os-
motic gradient (Fig. 4). This analysis revealed that sodium
sieving was significantly lower in females than males
(8.8 ± 0.6% vs. 11.6 ± 0.9%, P = 0.04), whereas MTAC
for urea and D120/D0 glucose were similar in both gen-
ders (Table 2). The gender difference in sodium sieving
was not reflected in terms of net UF.
To understand the molecular basis for this gender dif-
ference, we investigated the expression of AQP1 and
eNOS, which are 2 essential regulators of peritoneal per-
meability located in the capillary endothelium of the PM
(Fig. 5). Real-time RT-PCR showed that the expression
of Aqp1 mRNA was significantly lower in the visceral
peritoneum of female mice, whereas Enos mRNA ex-
pression was similar in both genders (Fig. 5A to D). Im-
munoblot analysis for AQP1 showed a major band at
28 kD in the visceral peritoneum; in comparison with
b-actin taken as a normalization marker, the expression
of AQP1 was lower in females than males (Fig. 5E). This
was confirmed by densitometry analysis (optical density
of AQP1/b-actin: 2.0 ± 0.2 AU in males vs. 1.2 ± 0.3 AU
in females, N = 4, P = 0.05).
These functional and molecular data demonstrate that
gender may affect the water permeability across the PM
in mouse, with females expressing significantly lower
amounts of the water channel AQP1 at the mRNA and
protein levels than males.
2028 Ni et al: Peritoneal dialysis parameters in mouse
0.0
0.5
1.0
D
/P
 u
re
a
0 30 60 90 120
A
Females (N = 6)
Males     (N = 6)
0.0
0.5
1.0
D
/D
0 
gl
uc
os
e
0 30 60 90 120
B
0.7
0.8
0.9
D
/P
 s
od
iu
m
0 30 60 90 120
C
Dwell time, minutes
*
Fig. 4. Peritoneal dialysis in mouse: Influence of gender. The dialysate-
to-plasma (D/P) ratio of urea (A), the progressive removal of glucose
from the dialysate (D/D0 glucose; B) and the sodium sieving (% de-
crease in D/P sodium from T0 to T30; C) were determined during a
2-hour exchange with 2 mL of 7% glucose dialysate in male (black tri-
angles) and female (open circles) mice. The permeability for urea and
glucose was very similar in both genders, whereas the sodium sieving
was significant lower in females as compared to males (∗P < 0.05).
DISCUSSION
In this study, we have characterized the structure and
the transport parameters of the PM in the C57BL/6J
mouse, one of the most common inbred strains used in
research. In the experimental conditions used, essential
peritoneal transport parameters are strikingly similar in
mouse and rat PM, including modifications induced by
variations in the dialysate volume and osmolality. Al-
though this is not a model of chronic PD, the data pre-
sented here complement our previous studies in mice [9],
and further emphasize the relevance of mouse models to
understand the pathophysiology of the PM in humans.
These results also suggest that gender has an influence
on the regulation of AQP1 and water transport across
the PM.
Morphologic studies (Figs. 1 and 2) demonstrated that
the general structure of the visceral and parietal peri-
toneum in mouse is undistinguishable from that described
in rat and man [11, 17, 20]. The luminal side of the
mesothelial cells showed numerous cytoplasmic exten-
sions corresponding to microvilli and primary cilia. These
structures are particularly developed in the visceral peri-
toneum, which may indicate a state of biosynthetic activa-
tion in these cells [21]. Most importantly, immunostaining
confirmed the specific distribution of AQP1 and eNOS in
distinct vascular beds in the PM. Like in rats and humans,
AQP1 is distributed in the endothelium lining peritoneal
capillaries and veinules, whereas eNOS is located in the
endothelium of all types of blood vessels [11, 17, 19]. The
specificity of endothelial distribution of these 2 proteins
(as well as their differential regulation, see below) con-
firms the functional heterogeneity of the vasculature in
the PM. It must be noted that, like in rats [17], AQP1 was
not detected by immunoelectron microscopy in mesothe-
lial cells. In contrast, AQP1 expression has been detected
in cultured mesothelial cells, with a significant induction
by exposure to osmotic agents [22]. These results could
be explained by a different state of differentiation of cul-
tured versus in situ mesothelial cells, or a level of AQP1
expression being too low in basal conditions to be de-
tected by immunostaining. In any case, the functional
importance of AQP1 in mesothelial cells, which do not
represent a significant functional barrier for water trans-
port in PD, remains unclear.
Analysis of the basal transport parameters in mice
showed a progressive increase in the D/P ratio for urea,
as well as a progressive reabsorption of glucose from the
dialysate. As expected, the scaling of dialysate volume to
BSA in mouse versus rat is reflected in terms of MTAC
for urea, whereas D120/D0 values and the UF normalized
per BW are almost identical in both species (Table 3). In
agreement with previous studies in man and rat [23, 24],
the MTAC for urea is significantly increased when using
higher inflow volumes. The use of higher inflow volumes
in mouse is also associated with a progressive increase
in UF, reflecting higher glucose load and a better main-
tenance of the glucose concentration gradient (Table 2)
[25].
The mechanism of UF in mouse was further investi-
gated by using different dialysate glucose concentrations
(Table 2, Fig. 3). The first observation was that MTAC
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Fig. 5. Gender effect of the expression of Aqp1 and Enos: real-time RT-PCR and immunoblot analysis. Representative real-time RT-PCR tracings
of Aqp1 versus GAPDH (A), and Enos versus GAPDH (B) in the visceral peritoneum of male and age-matched female mice. The duplicate curves
are shown. Quantification of the mRNA expression of Aqp1 (C) and Enos (D) in the visceral peritoneum of 6 age-matched males and females
(copies of Aqp1 and Enos normalized to copies of GAPDH). Representative immunoblots for AQP1 (1:20,000) in peritoneum extracts from male
and female mice (20 lg protein/lane) (E). The core (28 kD) AQP1 is detected in mouse peritoneum. Normalization for b-actin (after stripping and
reprobing the same blot at 1:10,000) confirms that the protein expression of AQP1 is lower in females (males: 2.0 ± 0.2 AU vs. females: 1.2 ± 0.3
AU, N = 4, P = 0.05) (F).
for urea is not influenced by glucose concentration, con-
firming previous studies in PD patients [2, 26]. Second,
the use of hypertonic dialysate in mouse was reflected by
sodium sieving, contrasting with a slight increase in the
D/P sodium when using 1.36% glucose dialysate. These
characteristics, as well as the fact that the magnitude
of sodium sieving correlated with the osmotic gradient,
are exactly similar to the findings in rat and human PM
[27]. Based on these properties and AQP1 distribution,
the sodium sieving observed in the mouse PM probably
reflects the facilitated transport of water across AQP1
molecules in the endothelium, secondary to the osmotic
gradient generated by glucose in the peritoneal cavity.
That the latter is the major force driving UF is further
demonstrated by the increase in UF observed when us-
ing 3.86% and 7% glucose dialysates. Thus, in mouse as
in rat, using hypertonic dwells will yield the most sensi-
tive testing of sodium sieving and UF volume [28]. Third,
our data in mice exposed to 7% dialysate show that high
UF can be achieved despite lower mean blood pressure
during the dwell, confirming the lack of influence of lim-
ited systemic BP variations on PD parameters [9, 12].
A chronic exposure to 7% glucose dialysate is certainly
detrimental for the PM; such toxicity has not been ob-
served in the single dwell experiments performed here.
Taken together, these novel observations in mice confirm
that net UF can be increased either by the use of larger
dialysate volumes (which increases the MTAC for urea
but decreases the rate of dilution), or by using more hy-
pertonic solutions (which increase the osmotic gradient).
Although our investigations focused on acute transport
parameters, it should be pointed out that the catheter was
well tolerated, and that previous experience [9] suggests
that this device can be used for evaluating the effect of
chronic exposure of the PM in mouse.
Gender influences body surface area and body com-
position, which clearly affects EPSA [1] and normal-
ization in clearances studies [29]. However, gender has
apparently no effect on small solute transport [30], and
its potential influence on water transport across the PM is
unknown. Our data, obtained on mice carefully matched
and exposed to 7% glucose to maximize the osmotic
gradient, clearly show that gender has no effect on the
MTAC for urea but does influence the expression of
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AQP1 in the PM. Compared to males, females showed a
lower expression of AQP1 in the PM (at the mRNA and
protein levels), reflected by a lower sodium sieving dur-
ing the PET (Figs. 4 and 5). Although the molecular ba-
sis of this gender effect on the transcription of Aqp1
is unknown, the relevance of glucocorticoids in regu-
lating AQP1 in the PM must be emphasized [17]. The
4.4-kb promoter of Aqp1 contains several glucocorticoid
response elements (GRE) that may bind to androgens
[31] (http://mordor.cgb.ki.se/cgi-bin/CONSITE/consite).
Females also express fewer glucocorticoid receptors in
the peritoneum [32]. The potential influence of the estrus
cycle on the expression of Aqp1 should also be consid-
ered. We can assume that the females used in this study,
which have never been exposed to males, were mixed in
terms of estrus cycle. Contrasting with AQP1, the lack of
gender effect on eNOS confirms previous studies show-
ing a lack of estrogen effect on eNOS expression in rat
mesenteric arteries [33].
CONCLUSION
These studies provide molecular and functional evi-
dence supporting the use of mice to investigate the patho-
physiology and molecular mechanisms of PD. They also
give new insights into the mechanisms of UF and the po-
tential influence of gender on water transport in the PM.
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